One of the major complications resulting from the viral infection is the onset of thrombotic events, and once again RES is able to mitigate this condition as it regulates the coagulation cascade [39] and acts as an antiplatelet agent through a COX-1 dependentmechanism [92] and eNOS dependent mechanism [93]. This evidence concerns the gene PTGS1 and viral infectious disease.